WHO ICTRP trial
Study of the efficacy of third-line eradication therapy with sitafloxacin in…
JPRN-UMIN000051852 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000051852 |
|---|---|
| Public title | Study of the efficacy of third-line eradication therapy with sitafloxacin in patients who failed Helicibacter pylori eradication |
| Scientific title | Study of the efficacy of third-line eradication therapy with sitafloxacin in patients who failed Helicibacter pylori eradication. - Study of the efficacy of third-line eradication therapy with sitafloxacin in patients who failed Helicibacter pylori eradication. |
| Primary sponsor | Oita University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Helicobacter pylori infection |
| Registration date | Jul 8, 2023 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: